- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.12. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::ANNOUNCEMENT OF CESSATION | 1 | SGX Company Announcements | ||
| 15.12. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| 09.12. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | 2 | SGX Company Announcements | ||
| 28.11. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| TIANJIN PHARMACEUTICAL DA REN TANG Aktie jetzt für 0€ handeln | |||||
| 28.11. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDTAE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 1 | SGX Company Announcements | ||
| 25.11. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON RECEIPT OF DRUG REGISTRATION CERTIFICATE | - | SGX Company Announcements | ||
| 24.11. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON CONVENING AN ONLINE CONFERENCE | 1 | SGX Company Announcements | ||
| 30.10. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | - | SGX Company Announcements | ||
| 30.10. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::AMENDMENTS TO THE ARTICLES OF ASSOCIATION OF THE COMPANY | - | SGX Company Announcements | ||
| 30.10. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 6TH BOARD MEETING FOR FY2025 | - | SGX Company Announcements | ||
| 30.10. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::THIRD QUARTER RESULTS | - | SGX Company Announcements | ||
| 30.10. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDTAE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | - | SGX Company Announcements | ||
| 30.09. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDTAE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 7 | SGX Company Announcements | ||
| 03.09. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON CONVENING AN ONLINE CONFERENCE | 2 | SGX Company Announcements | ||
| 29.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDTAE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | - | SGX Company Announcements | ||
| 25.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON THE EVALUATION REPORT ON THE 2024 ACTION PLAN AND ON THE 2025 ACTION PLAN | 1 | SGX Company Announcements | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::PROPOSED PURCHASE OF LIABILITY INSURANCE FOR THE COMPANY | - | SGX Company Announcements | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::UPDATE ANNOUNCEMENT ON CONTINUOUS RISK ASSESSMENT REPORT OF TPGF | - | SGX Company Announcements | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON THE DEPOSIT OF NET PROCEEDS AND THE USE OF NET PROCEEDS | - | SGX Company Announcements | ||
| 14.08. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::RESOLUTIONS PASSED AT THE 5TH BOARD MEETING FOR FY2025 | - | SGX Company Announcements |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRAZENECA | 157,25 | +0,83 % | Studienziel verfehlt: Lungenkrebs-Hoffnung geplatzt: AstraZeneca meldet herben Rückschlag! | © Foto: SOPA Images - picture alliance / Sipa USAAstraZeneca scheitert mit einer vielversprechenden Wirkstoffkombination in einer Spätstudie zu Lungenkrebs. Der Konzern bleibt dennoch kämpferisch.AstraZeneca... ► Artikel lesen | |
| TEVA | 26,700 | -0,37 % | Teva Pharmaceutical Industries Ltd: S&P Global Ratings Upgrades Teva to 'BB+' Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive | The two updates underscore Teva's strong execution of its Pivot to Growth strategy and commitment to financial discipline.Moody's affirmed Teva's B1a rating and revised Teva's outlook to positive from... ► Artikel lesen | |
| SINOPHARM | 2,108 | -0,89 % | SINOPHARM (01099): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | ||
| CSPC PHARMA | 0,975 | +1,61 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - DARATUMUMAB INJECTION OBTAINS CLINICAL TRIAL APPROVAL IN CHINA | ||
| WUXI BIOLOGICS | 3,600 | -0,33 % | HSI Rises 165 Pts at Midday; HSBC HOLDINGS Hits New Highs; WUXI BIO Surges 6%+ | ||
| OPKO HEALTH | 1,116 | +0,04 % | OPKO Health, Inc.: OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results | MIAMI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and nine months ended September 30, 2025. Highlights... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 2,222 | -0,71 % | VC Aditum Bio launches new biotech in business play with Fosun Pharma | ||
| GEDEON RICHTER | 24,620 | -2,46 % | Gedeon Richter Plc.: Extraordinary Information | ||
| DR REDDYS | 11,900 | 0,00 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer | ||
| THC BIOMED | 0,011 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.09.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 23.09.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.09.2025.ISIN NameAU0000221251 LEO... ► Artikel lesen | |
| NOVO NORDISK | 43,935 | -0,10 % | Novo Nordisk-Aktie: Kann das die Trendwende bringen? | Die Novo Nordisk-Aktie hat sich in den letzten Wochen knapp über der Marke von 40 € stabilisiert. Eine Trendwende nach oben zeichnet sich allerdings noch nicht ab. Könnte diese neue Nachricht dem dänischen... ► Artikel lesen | |
| BAYER | 35,940 | +1,37 % | Novo Nordisk glänzt mit neuer Zulassung, Bayer erhält in Japan grünes Licht, DroneShield baut Vertrauen auf und TUI beschenkt Anleger mit neuen Höchstständen | An den US-Börsen findet heute noch einmal ein verkürzter Handel statt. Hierzulande haben sich die Märkte derweil in ein langes Weihnachtswochenende verabschiedet. Pünktlich zum Fest gab es dabei in... ► Artikel lesen | |
| MERCK KGAA | 120,55 | +0,37 % | JPMORGAN stuft MERCK KGAA auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Merck KGaA nach Gesprächen mit dem Management auf "Overweight" mit einem Kursziel von 150 Euro belassen. In seiner Elektroniksparte... ► Artikel lesen | |
| PFIZER | 21,120 | +0,05 % | Pfizer Aktie unter Druck - lohnt es sich jetzt, Aktien zu kaufen? | ||
| HARROW | 50,23 | +2,20 % | Harrow, Inc.: Harrow Health, Inc. Announces Closing of Acquisition of Melt Pharmaceuticals | NASHVILLE, Tenn., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has completed the... ► Artikel lesen |
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORP LTD gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von -0,034 (-1,17 %) liegt der Kurs bei 2,869 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORP LTD finden Sie auf Wallstreet Online.